Results 51 to 60 of about 109,236 (214)

Evaluating the (comparative) safety profile of the novel oral polio vaccine type 2 using individual case safety reports in VigiBase

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim Novel oral polio vaccine type 2 (nOPV2) was used under the WHO emergency use listing for circulating vaccine‐derived polio virus (cVDPV) outbreaks from 2021 to 2023. We assessed nOPV2 adverse events following immunization (AEFIs) and compared its safety profile to other vaccines using VigiBase.
Comfort Kunak Ogar   +6 more
wiley   +1 more source

Foreign Accent Syndrome Mimicked by Garcin Syndrome with Spontaneous Resolution

open access: yesBehavioural Neurology, 2008
An English speaking women developed a French accent, without any aphasic syndromes, in conjunction with multiple left sided cranial nerve deficits, temporally related to cranial trauma.
Michael Hoffmann
doaj   +1 more source

Diffuse Leptomeningeal Glioneuronal Tumor Presenting as Progressive Cranial Neuropathies

open access: yes, 2022
We present a unique case of Diffuse leptomeningeal glioneuronal tumor (DLGT) presenting as stroke-like symptoms with progressive cranial ...
Mohammad A. Siddiqui; Paul Phillips; Sarkis Nazarian; Raghu Ramakrishnaiah; Murat Gokden; Joseph Chacko
core  

Developmental Morphometry of the Paranasal Sinuses in Subjects Aged 1–25 Years: A Computed Tomography Study

open access: yesClinical Anatomy, EarlyView.
ABSTRACT The present study aimed to evaluate the developmental morphometry of the paranasal sinuses using computed tomography (CT) in subjects aged 1–25 years and to characterize age‐related changes in sinus dimensions, volume, and surface area throughout childhood, adolescence, and young adulthood.
Ceyda Şevval Çetin   +4 more
wiley   +1 more source

Trigeminal Neuralgia with Persistent Trigeminal Artery Variant and Schwannomatosis of the Abducens and Lower Cranial Nerves: A Case Report

open access: yesJournal of the Korean Society of Radiology
Multiple cranial neuropathies are complex neurological disorders that present significant treatment challenges due to their intricate and multifaceted underlying causes.
Seong Gwang Kim   +4 more
doaj   +1 more source

A metric study of three types of artificial cranial modification from north-central Peru

open access: yes, 2010
Artificial cranial modification (ACM) involves the alteration of cranial vault shape by cultural means, and is performed during infancy while the cranial bones remain soft and malleable.
Zakrzewski, Sonia   +3 more
core   +1 more source

Opsoclonus in Pediatric Patients: Differential Diagnosis and a Practical Approach to Evaluation

open access: yesAnnals of the Child Neurology Society, EarlyView.
ABSTRACT Opsoclonus is an ocular dyskinesia characterized by involuntary, arrhythmic, multidirectional saccades. In pediatrics, opsoclonus is most commonly attributed to the rare neuroinflammatory disorder opsoclonus‐myoclonus‐ataxia syndrome (OMAS), typically considered a paraneoplastic syndrome associated with neural crest tumors. However, opsoclonus
Aubrey C. Reed   +5 more
wiley   +1 more source

Multiple cranial neuropathies as a manifestation of paraneoplastic syndrome in thymoma

open access: yesНеврология, нейропсихиатрия, психосоматика, 2022
Neurological symptoms could be a manifestation of cancer both with direct involvement of the nervous system (tumor invasion, metastasis, compression of nerve tissue by neoplasm) and its mediated damage in patients with paraneoplastic syndromes ...
G. R. Ramazanov   +5 more
doaj   +1 more source

Cranial Nerve Neuropathies in Diffuse Large B-Cell Lymphoma (DLBCL): Case Presentation and a Systematic Review of the Literature

open access: yes, 2022
A systematic review looking at cranial nerve neuropathies present in ...
Bahadar Srichawla
core   +1 more source

Toward Fit‐for‐Purpose Data for Drug Assessment in Non‐small Cell Lung Cancer: A Core Dataset

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Considering the high unmet medical need in people with non‐small cell lung cancer (NSCLC), the drug assessment for targeted therapies often rely on small populations and single‐arm trials, challenging the evaluation by regulatory authorities, health technology assessment bodies (HTAb), and clinicians.
Geeske F. Grit   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy